Analysis for Prognostic Factors from a Database for the Intra-Articular Hyaluronic Acid (Euflexxa) Treatment for Osteoarthritis of the Knee

Roy D Altman, Forough Farrokhyar, Anke Fierlinger, Faizan Niazi, Jeffrey Rosen

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Introduction: Intra-articular hyaluronic acid (IA-HA) injections are a treatment for knee osteoarthritis (OA), although current literature provides mixed results with regard to their efficacy. We will review a randomized controlled trial (RCT) and subsequent extension trial in order to identify factors that are associated with outcomes in patients with knee OA who received IA-HA. Methods: We used data recorded by the FLEXX trial and extension trial for secondary analysis of potential prognostic factors. Linear regression was used to examine the predictors of outcomes at 6- and 12-month follow-up visits. Results: Sixty percent of all patients presented with a Kellgren Lawrence (K-L) grade 3. Patients with high baseline outcome scores and a K-L grade 3 demonstrated less response than individuals within an earlier stage of knee OA, although results for both K-L grade 2 and K-L grade 3 patients still showed benefit. Those with more severe radiographic change K-L grade 3 often had a better response with the second series of IA-HA injections. Significantly greater positive response in all outcomes was demonstrated for the patient subgroup classified as K-L grade 2, when compared with K-L grade 3 patients. Conclusions: The results demonstrate that IA-HA for knee OA was of greater benefit in those with less severe radiographic changes. However, those with more severe radiographic change often had a better response with the second course of IA-HA. Similar analyses are required in order to determine if these results are unique to Euflexxa, or if these results are consistent with other available IA-HA agents.

Original languageEnglish (US)
Pages (from-to)229-237
Number of pages9
JournalCartilage
Volume7
Issue number3
DOIs
StatePublished - Jul 1 2016
Externally publishedYes

Fingerprint

Hyaluronic acid
Knee Osteoarthritis
Hyaluronic Acid
Joints
Databases
Therapeutics
Injections
Linear regression
Linear Models
Randomized Controlled Trials

Keywords

  • diagnosis
  • intraarticular delivery
  • joint involved
  • knee
  • osteoarthritis
  • therapeutic delivery

ASJC Scopus subject areas

  • Immunology and Allergy
  • Biomedical Engineering
  • Physical Therapy, Sports Therapy and Rehabilitation

Cite this

Analysis for Prognostic Factors from a Database for the Intra-Articular Hyaluronic Acid (Euflexxa) Treatment for Osteoarthritis of the Knee. / Altman, Roy D; Farrokhyar, Forough; Fierlinger, Anke; Niazi, Faizan; Rosen, Jeffrey.

In: Cartilage, Vol. 7, No. 3, 01.07.2016, p. 229-237.

Research output: Contribution to journalArticle

Altman, Roy D ; Farrokhyar, Forough ; Fierlinger, Anke ; Niazi, Faizan ; Rosen, Jeffrey. / Analysis for Prognostic Factors from a Database for the Intra-Articular Hyaluronic Acid (Euflexxa) Treatment for Osteoarthritis of the Knee. In: Cartilage. 2016 ; Vol. 7, No. 3. pp. 229-237.
@article{187252459c424b5bb4513d84a369486f,
title = "Analysis for Prognostic Factors from a Database for the Intra-Articular Hyaluronic Acid (Euflexxa) Treatment for Osteoarthritis of the Knee",
abstract = "Introduction: Intra-articular hyaluronic acid (IA-HA) injections are a treatment for knee osteoarthritis (OA), although current literature provides mixed results with regard to their efficacy. We will review a randomized controlled trial (RCT) and subsequent extension trial in order to identify factors that are associated with outcomes in patients with knee OA who received IA-HA. Methods: We used data recorded by the FLEXX trial and extension trial for secondary analysis of potential prognostic factors. Linear regression was used to examine the predictors of outcomes at 6- and 12-month follow-up visits. Results: Sixty percent of all patients presented with a Kellgren Lawrence (K-L) grade 3. Patients with high baseline outcome scores and a K-L grade 3 demonstrated less response than individuals within an earlier stage of knee OA, although results for both K-L grade 2 and K-L grade 3 patients still showed benefit. Those with more severe radiographic change K-L grade 3 often had a better response with the second series of IA-HA injections. Significantly greater positive response in all outcomes was demonstrated for the patient subgroup classified as K-L grade 2, when compared with K-L grade 3 patients. Conclusions: The results demonstrate that IA-HA for knee OA was of greater benefit in those with less severe radiographic changes. However, those with more severe radiographic change often had a better response with the second course of IA-HA. Similar analyses are required in order to determine if these results are unique to Euflexxa, or if these results are consistent with other available IA-HA agents.",
keywords = "diagnosis, intraarticular delivery, joint involved, knee, osteoarthritis, therapeutic delivery",
author = "Altman, {Roy D} and Forough Farrokhyar and Anke Fierlinger and Faizan Niazi and Jeffrey Rosen",
year = "2016",
month = "7",
day = "1",
doi = "10.1177/1947603515620890",
language = "English (US)",
volume = "7",
pages = "229--237",
journal = "Cartilage",
issn = "1947-6035",
publisher = "SAGE Publications Inc.",
number = "3",

}

TY - JOUR

T1 - Analysis for Prognostic Factors from a Database for the Intra-Articular Hyaluronic Acid (Euflexxa) Treatment for Osteoarthritis of the Knee

AU - Altman, Roy D

AU - Farrokhyar, Forough

AU - Fierlinger, Anke

AU - Niazi, Faizan

AU - Rosen, Jeffrey

PY - 2016/7/1

Y1 - 2016/7/1

N2 - Introduction: Intra-articular hyaluronic acid (IA-HA) injections are a treatment for knee osteoarthritis (OA), although current literature provides mixed results with regard to their efficacy. We will review a randomized controlled trial (RCT) and subsequent extension trial in order to identify factors that are associated with outcomes in patients with knee OA who received IA-HA. Methods: We used data recorded by the FLEXX trial and extension trial for secondary analysis of potential prognostic factors. Linear regression was used to examine the predictors of outcomes at 6- and 12-month follow-up visits. Results: Sixty percent of all patients presented with a Kellgren Lawrence (K-L) grade 3. Patients with high baseline outcome scores and a K-L grade 3 demonstrated less response than individuals within an earlier stage of knee OA, although results for both K-L grade 2 and K-L grade 3 patients still showed benefit. Those with more severe radiographic change K-L grade 3 often had a better response with the second series of IA-HA injections. Significantly greater positive response in all outcomes was demonstrated for the patient subgroup classified as K-L grade 2, when compared with K-L grade 3 patients. Conclusions: The results demonstrate that IA-HA for knee OA was of greater benefit in those with less severe radiographic changes. However, those with more severe radiographic change often had a better response with the second course of IA-HA. Similar analyses are required in order to determine if these results are unique to Euflexxa, or if these results are consistent with other available IA-HA agents.

AB - Introduction: Intra-articular hyaluronic acid (IA-HA) injections are a treatment for knee osteoarthritis (OA), although current literature provides mixed results with regard to their efficacy. We will review a randomized controlled trial (RCT) and subsequent extension trial in order to identify factors that are associated with outcomes in patients with knee OA who received IA-HA. Methods: We used data recorded by the FLEXX trial and extension trial for secondary analysis of potential prognostic factors. Linear regression was used to examine the predictors of outcomes at 6- and 12-month follow-up visits. Results: Sixty percent of all patients presented with a Kellgren Lawrence (K-L) grade 3. Patients with high baseline outcome scores and a K-L grade 3 demonstrated less response than individuals within an earlier stage of knee OA, although results for both K-L grade 2 and K-L grade 3 patients still showed benefit. Those with more severe radiographic change K-L grade 3 often had a better response with the second series of IA-HA injections. Significantly greater positive response in all outcomes was demonstrated for the patient subgroup classified as K-L grade 2, when compared with K-L grade 3 patients. Conclusions: The results demonstrate that IA-HA for knee OA was of greater benefit in those with less severe radiographic changes. However, those with more severe radiographic change often had a better response with the second course of IA-HA. Similar analyses are required in order to determine if these results are unique to Euflexxa, or if these results are consistent with other available IA-HA agents.

KW - diagnosis

KW - intraarticular delivery

KW - joint involved

KW - knee

KW - osteoarthritis

KW - therapeutic delivery

UR - http://www.scopus.com/inward/record.url?scp=84976417382&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84976417382&partnerID=8YFLogxK

U2 - 10.1177/1947603515620890

DO - 10.1177/1947603515620890

M3 - Article

AN - SCOPUS:84976417382

VL - 7

SP - 229

EP - 237

JO - Cartilage

JF - Cartilage

SN - 1947-6035

IS - 3

ER -